← Eichor
Study identifier: NCT05918263 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

Condition: Prostate Cancer · Prostatic Neoplasms  ·  Sponsor: Fred Hutchinson Cancer Center

PhaseNA
Planned participants68
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine whether a 12-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among men with prostate cancer at high-risk of progression undergoing active surveillance. The name of the study intervention involved in this study is: Aerobic high-intensity interval training (HIIT) (training exercise intervention)

This description comes directly from the study's public registry record.

Talk to the study team

Dong-Woo Kang, PhD  ·  206-667-5188  ·  dkang@fredhutch.org

Always discuss trial participation with your own doctor first.

Locations (4)

Beth Israel Deaconess Medical CenterBoston, Massachusetts, United StatesCompleted
Brigham and Women's HospitalBoston, Massachusetts, United StatesCompleted
Dana-Farber Cancer InstituteBoston, Massachusetts, United StatesCompleted
Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05918263